Besides anti-vascular endothelial growth factor (anti-VEGF) therapy, photodynamic therapy (FDT) and combination therapies are currently being used in the treatment of PVC
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Polypoidal choroidal vasculopathy (PCV), characterized by aneurysmal polypoidal lesions in the choroidal vasculature, is a subtype of exudative age-related macular degeneration (AMD) which can cause permanent vision loss due to hemorrhage, exudation, macular edema, and disciform scar formation.
📊
Key Findings & Data:Polypoidal choroidal vasculopathy (PCV), characterized by aneurysmal polypoidal lesions in the choroidal vasculature, is a subtype of exudative age-related macular degeneration (AMD) which can cause permanent vision loss due to hemorrhage, exudation, macular edema, and disciform scar formation.
💡
Conclusion & Impact:Besides anti-vascular endothelial growth factor (anti-VEGF) therapy, photodynamic therapy (FDT) and combination therapies are currently being used in the treatment of PVC
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Polypoidal choroidal vasculopathy (PCV), characterized by aneurysmal polypoidal lesions in the choroidal vasculature, is a subtype of exudative age-related macular degeneration (AMD) which can cause permanent vision loss due to hemorrhage, exudation, macular edema, and disciform scar formation. Besides anti-vascular endothelial growth factor (anti-VEGF) therapy, photodynamic therapy (FDT) and combination therapies are currently being used in the treatment of PVC
Özet
Polipoidal koroidal vaskülopati (PKV), koroid düzeyinde anevrizmal polipoidal lezyonlar ile seyreden; hemoraji, eksüdasyon, maküler ödem ve diskiform skar formasyonu nedeniyle kalıcı görme kaybına neden olabilen, eksüdatif yaşa bağlı maküla dejenerasyonun (YBMD) bir alt tipidir. PKV tedavisinde anti-vasküler endotelyal büyüme faktörü (antiVEGF) yanında fotodinamik tedavi (FDT) ve kombine tedaviler güncelliğini korumaktadır
🔖
Cite This Article
ÖNER, F. H., KAYA, M. (2017). Polypoidal Choroidal Vasculopathy and Treatments. Güncel Retina Dergisi, Cilt: 1 - Sayı: 3, 262–267. https://ajindex.com/articles/216932
References (12)
Wong RL, Lai TY. Polypoidal choroidal vasculopathy: an update on therapeutic approaches. J Ophthal Vis Res. 2013;8(4):359-371
Koh AH; Expert PCV Panel, Chen LJ, Chen SJ, Chen Y, Giridhar A., et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina. 2013;33(4):686-716
Nakashizuka H, Mitsumata M, Okisaka S, Shimada H, Kawamura A, Mori R., et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2008;49(11):4729-4737
Gomi F, Tano Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol. 2008;19(3):208-212
Hatz K, Prünte C. Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response. Br J Ophthalmol. 2014;98(2):188-194
Tan CS, Lim LW, Ngo WK, Lim TH. Polypoidal choroidal vasculopathy in patients diagnosed with age-related macular degeneration. Acta Ophthalmol. 2013;91(7):578-579
Liang XY, Lai TY, Liu DT, Fan AH, Chen LJ, Tam PO., et al. Differentiation of exudative age-related macular degeneration and polypoidal choroidal vasculopathy in the ARMS2/HTRA1 locus. Invest Ophthalmol Vis Sci. 2012;53(6):3175-3182
Zhang X, Li M, Wen F, Zuo C, Chen H, Wu K, et al. Different impact of high-density lipoprotein-related genetic variants on polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population. Exp Eye Res. 2013;108(3):16-22
Zhang X, Wen F, Zuo C, Li M, Chen H, Wu K. Association of genetic variation on chromosome 9p21 with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(11):8063-8067
Kikuchi M, Nakamura M, Ishikawa K, Suzuki T, Nishihara H, Yamakoshi T, et al. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology. 2007;114(9):1722-1727
Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol. 2006;141(3):456-462
Ojima Y, Hangai M, Sakamoto A, Tsujikawa A, Otani A, Tamura H, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina. 2009;